Broomfield company searching for Ebola answers

BROOMFIELD – The Ebola outbreak that began last month in Guinea may be half a world away, but for researchers at Broomfield-based Corgenix Medical Corp. it’s another call to action.

Ebola hemorrhagic virus, as the disease is officially known, causes massive hemorrhaging in its victims, ultimately resulting in organ failure and, 90 percent of the time, death. There is no treatment for the highly contagious virus, which lies mostly dormant in West Africa, popping up every few years, said Corgenix chief executive Doug Simpson.
Corgenix (OTC BB:CONX)…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!